ANDREA GILLON: Open Payments
NPI 1952799850 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 15 payments from 11 companies in 2025. Trend: 2023 $942 · 2024 $885 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 1 | $178 |
| TG Therapeutics, Inc. | 1 | $140 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $125 |
| Alnylam Pharmaceuticals Inc. | 1 | $77 |
| Genentech USA, Inc. | 3 | $71 |
| ABBVIE INC. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
Products named: Gamunex-C, BRIUMVI, ULTOMIRIS, VYVGART, AMVUTTRA, SKYRIZI, Xolair, HYQVIA.
Industry payments across MI — which companies pay providers there.
